Jongen, Lynn
Floris, Giuseppe
Boeckx, Bram
Smeets, Dominiek
Lambrechts, Diether
Vander Borght, Sara
Laenen, Annouschka
Mann, Grace
Cutler, Richard E. Jr.
Lalani, Alshad S.
Neven, Patrick
Wildiers, Hans http://orcid.org/0000-0001-8990-7837
Funding for this research was provided by:
Puma Biotechnology, Inc.
Article History
Received: 3 November 2018
Accepted: 13 November 2018
First Online: 19 November 2018
Compliance with ethical standards
:
: HW is recipient of The Research Foundation - Flanders (FWO). HW received consulting fees, travel support, and research support from Puma Biotechnologies, Inc (all provided to his institute), and he received speaker’s fees, consulting fees, travel support, and research support from Roche (all provided to his institute). LJ received a grant from Puma Biotechnologies, Inc. GM, AL, and RC received salary and have ownership interest in Puma Biotechnologies, Inc. PN received speaker’s fees, consulting fees, travel support, and research support from Roche (all provided to his institute). PN is on the advisory board of Novartis, AstraZeneca, Lilly, and Pfizer (all consulting fees are provided to his institute).
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional committee (University Hospitals Leuven, Belgium) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Patients were only included if they provided a written informed consent at time of diagnosis for future research on their resected tumour tissue. This article does not contain any studies with animals performed by any of the authors.